Advanced search
Publication Cover
Acta Oncologica Volume 54, 2015 - Issue 3
Journal homepage
5,731
Views
138
CrossRef citations to date
0
Altmetric
Brain tumour

Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer

Guro B. SteneEuropean Palliative Care Research Centre, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway;The Cancer Clinic, St. Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway;Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, NorwayCorrespondence[email protected]
,
Jorunn L. HelbostadDepartment of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway;Department of Clinical Services, St. Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway
,
Tore AmundsenDepartment of Thoracic Medicine, St. Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway;Department of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway
,
Sveinung SørhaugEuropean Palliative Care Research Centre, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway;Department of Thoracic Medicine, St. Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway
,
Harald HjeldeDepartment of Thoracic Medicine, St. Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway
,
Stein KaasaEuropean Palliative Care Research Centre, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway;The Cancer Clinic, St. Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway
&
Bjørn H. GrønbergEuropean Palliative Care Research Centre, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway;The Cancer Clinic, St. Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway
 show all
Pages 340-348 | Received 19 May 2014, Accepted 03 Aug 2014, Published online: 16 Sep 2014

Citations (138)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Uzair Jogiat, Zaharadeen Jimoh, Simon R. Turner, Vickie Baracos, Dean Eurich & Eric L. R. Bédard. (2023) Sarcopenia in Lung Cancer: A Narrative Review. Nutrition and Cancer 75:7, pages 1485-1498.
Read now
Sandra Jensen, Zina Bloch, Morten Quist, Tobias Tuse Dunk Hansen, Christoffer Johansen, Helle Pappot, Charlotte Suetta & Bolette Skjødt Rafn. (2023) Sarcopenia and loss of muscle mass in patients with lung cancer undergoing chemotherapy treatment: a systematic review and meta-analysis. Acta Oncologica 62:3, pages 318-328.
Read now
Elanur Karaman, Nur Hursoy & Sibel Goksel. (2023) The Effect of Sarcopenia and Metabolic PET-CT Parameters on Survival in Locally Advanced Non-Small Cell Lung Carcinoma. Nutrition and Cancer 75:1, pages 286-295.
Read now
Alice Avancini, Lorenzo Belluomini, Anita Borsati, Silvia Teresa Riva, Ilaria Trestini, Daniela Tregnago, Alessandra Dodi, Massimo Lanza, Cecilia Pompili, Renzo Mazzarotto, Claudio Micheletto, Massimiliano Motton, Aldo Scarpa, Federico Schena, Michele Milella & Sara Pilotto. (2022) Integrating supportive care into the multidisciplinary management of lung cancer: we can’t wait any longer. Expert Review of Anticancer Therapy 22:7, pages 725-735.
Read now
Denise K. Gabrielson, Christine Brezden-Masley, Mary Keith, Richard P. Bazinet, Jenna Sykes & Pauline B. Darling. (2021) Evaluation of Nutritional, Inflammatory, and Fatty Acid Status in Patients with Gastric and Colorectal Cancer Receiving Chemotherapy. Nutrition and Cancer 73:3, pages 420-432.
Read now
Bengt Glimelius. (2018) More than 1000 new manuscripts in 2017. Acta Oncologica 57:2, pages 174-175.
Read now
Hiroshi Fukushima & Fumitaka Koga. (2017) Impact of sarcopenia in the management of urological cancer patients. Expert Review of Anticancer Therapy 17:5, pages 455-466.
Read now

Articles from other publishers (131)

Verônica Torres. (2023) Serum cystatin C level can be used to estimate GFR in patients with solid tumors: PRO. Journal of Onco-Nephrology 7:3, pages 135-139.
Crossref
Song Ee Park, Du Hwan Kim, Don-Kyu Kim, Joo Young Ha, Joung-Soon Jang, Jin Hwa Choi & In Gyu Hwang. (2023) Feasibility and safety of exercise during chemotherapy in people with gastrointestinal cancers: a pilot study. Supportive Care in Cancer 31:10.
Crossref
Pamela N. Klassen, Vickie Baracos, Sunita Ghosh, Lisa Martin, Michael B. Sawyer & Vera C. Mazurak. (2023) Muscle and Adipose Wasting despite Disease Control: Unaddressed Side Effects of Palliative Chemotherapy for Pancreatic Cancer. Cancers 15:17, pages 4368.
Crossref
Hui-xian Li, Hui Zheng, Wei Tang, Yong-kun Sun, Lin Zhang, Xiang-yi Kong & Tao Yan. (2023) Postoperative recurarization after sugammadex administration in two patients who received neoadjuvant chemotherapy: case reports and literature reviewRécurarisation postopératoire après administration de sugammadex chez deux patient·es ayant reçu une chimiothérapie néoadjuvante : présentations de cas et revue de la littérature. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 70:9, pages 1529-1538.
Crossref
Victoria Salati, Katerina Mandralis, Fabio Becce, Joachim Koerfer, Karma Lambercy, Christian Simon & François Gorostidi. (2023) Preoperative CT-Based Skeletal Muscle Mass Depletion and Outcomes after Total Laryngectomy. Cancers 15:14, pages 3538.
Crossref
Austin M. Meggyesy, Candice L. Wilshire, Shu-Ching Chang, Jed A. Gorden & Christopher R. Gilbert. (2023) Muscle mass cross-sectional area is associated with survival outcomes in malignant pleural disease related to lung cancer. Respiratory Medicine, pages 107371.
Crossref
Clarissa Polen-De, Smith Giri, Priyal Fadadu, Amy Weaver, Michaela E Mcgree, Michael Moynagh, Naoki Takahashi, Aminah Jatoi, Nathan K Lebrasseur, William Cliby, Grant Williams & Amanika Kumar. (2023) Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer. JNCI Monographs 2023:61, pages 43-48.
Crossref
Hui Yuan, Xiaoyue Tan, Xiaolin Sun, Li He, Dongjiang Li & Lei Jiang. (2022) Role of 18F-FDG PET/CT and sarcopenia in untreated non-small cell lung cancer with advanced stage. Japanese Journal of Radiology 41:5, pages 521-530.
Crossref
Eun Soo Park, Jong Hee Kim, Soo Dam Kim, Dong Hyun Kim, Min Seok Oh, Eun Jung Lee & Hwa Seung Yoo. (2023) Effects of Neuromuscular Electrical Stimulation on Muscle Wasting with Cancer Patient: Study Protocol for a Systematic Review. Journal of Korean Medicine Rehabilitation 33:2, pages 49-55.
Crossref
Lingli Luo, Xiangru Shen, Shuai Fang, Teng Wan, Pan Liu, Peiling Li, Haifeng Tan, Yong Fu, Weiming Guo & Xiaojun Tang. (2023) Sarcopenia as a risk factor of progression-free survival in patients with metastases: a systematic review and meta-analysis. BMC Cancer 23:1.
Crossref
Dongjiang Li, Xiaoyue Tan, Hui Yuan, Xinchao Yao, Xiaolin Sun, Li He & Lei Jiang. (2023) Usefulness of 18F-FDG PET/computed tomography metabolic parameters in predicting sarcopenia and prognosis of treatment-naive patients with non-small cell lung cancer. Nuclear Medicine Communications Publish Ahead of Print.
Crossref
Daisuke Suzuki, Ryoji Kobayashi, Masaki Yamamoto, Satoru Matsushima, Daiki Hori, Masato Yanagi, Koya Kodama, Hirozumi Sano, Yusuke Akane, Keita Igarashi & Kunihiko Kobayashi. (2022) Impact of muscle loss in children with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation. International Journal of Hematology 117:1, pages 128-133.
Crossref
Shuang Liu & Masaki Mogi. 2023. Cancer Research: An Interdisciplinary Approach. Cancer Research: An Interdisciplinary Approach 567 587 .
Shinya Ito, Hisae Hayashi, Yukiya Matsumoto, Risa Nakano, Yuta Yasukochi, Tetsuro Haraguchi & Hiroshi Inoue. (2022) Comorbidity and Prognostic Impact of Sarcopenia in Patients with Advanced Non-small-cell Lung Cancer進行非小細胞肺癌患者におけるサルコペニア併存率および予後への影響. Haigan 62:7, pages 975-982.
Crossref
Tsuyoshi Harada, Tetsuya Tsuji, Junya Ueno, Yu Koishihara, Nobuko Konishi, Nanako Hijikata, Aiko Ishikawa, Daisuke Kotani, Takashi Kojima, Hisashi Fujiwara & Takeo Fujita. (2022) Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer. Annals of Surgical Oncology 29:13, pages 8131-8139.
Crossref
Ting Xu, Zhenhao Li, Hui Li, Jixiang Hou, Jingjing Li, Gaowa Jin, Shaohua Li & Quanfu Li. (2022) Dynamic changes in the body composition during chemotherapy for gastrointestinal tumors in the context of active nutrition intervention. Frontiers in Oncology 12.
Crossref
Ting-Yu Lin, Yen-Fu Chen, Wei-Ting Wu, Der-Sheng Han, I.-Chen Tsai, Ke-Vin Chang & Levent Özçakar. (2022) Impact of sarcopenia on the prognosis and treatment of lung cancer: an umbrella review. Discover Oncology 13:1.
Crossref
Kuan Liao, Tianxiao Wang, Jake Coomber-Moore, David C Wong, Fabio Gomes, Corinne Faivre-Finn, Matthew Sperrin, Janelle Yorke & Sabine N van der Veer. (2022) Prognostic value of patient-reported outcome measures (PROMs) in adults with non-small cell Lung Cancer: a scoping review. BMC Cancer 22:1.
Crossref
Thomas Vanhoutte & Ben Sprangers. (2022) Serum cystatin C level can be used to estimate GFR in patients with solid tumors: Moderator Commentary. Journal of Onco-Nephrology 6:3, pages 119-124.
Crossref
Clarissa Polen-De, Priyal Fadadu, Amy L Weaver, Michael Moynagh, Naoki Takahashi, Aminah Jatoi, Nathan K LeBrasseur, Michaela McGree, William Cliby & Amanika Kumar. (2022) Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer. International Journal of Gynecologic Cancer 32:10, pages 1289-1296.
Crossref
Anthea Phuong, J. Peter Marquardt, Ryan O'Malley, Sarah K. Holt, Grace Laidlaw, Zachary Eagle, Steven Ngo, Delaney Orcutt, George R. Schade, Daniel W. Lin, Michael T. Schweizer, Todd Yezefski, Evan Y. Yu, Bruce Montgomery, Petros Grivas, Florian J. Fintelmann & Sarah P. Psutka. (2022) Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events. Urologic Oncology: Seminars and Original Investigations 40:10, pages 456.e19-456.e30.
Crossref
K. Ururi-Cupi, F. Oliva-Zapata, L. Salazar-Talla, S. Cuba-Ruiz, Diego Urrunaga-Pastor, Fernando M. Runzer-Colmenares & J. F. Parodi. (2022) SARC-F and SARC-CalF Scores as Mortality Risk Factors in Older Men with Cancer: A Longitudinal Study from Peru. The journal of nutrition, health & aging.
Crossref
Konstantinos Prokopidis, Panagiotis Giannos, Oliver C. Witard, Daniel Peckham & Theocharis Ispoglou. (2022) Aberrant mitochondrial homeostasis at the crossroad of musculoskeletal ageing and non-small cell lung cancer. PLOS ONE 17:9, pages e0273766.
Crossref
Qian Sun, Xiaohan Jiang, Rui Qin, Yuanyuan Yang, Yabo Gong, Kunyuan Wang & Junsheng Peng. (2022) Sarcopenia among older patients with cancer: A scoping review of the literature. Journal of Geriatric Oncology 13:7, pages 924-934.
Crossref
Wouter A. C. van Amsterdam, Netanja I. Harlianto, Joost J. C. Verhoeff, Pim Moeskops, Pim A. de Jong & Tim Leiner. (2022) The Association between Muscle Quantity and Overall Survival Depends on Muscle Radiodensity: A Cohort Study in Non-Small-Cell Lung Cancer Patients. Journal of Personalized Medicine 12:7, pages 1191.
Crossref
Ting Xu, Zhen-Hao Li, Ting Liu, Cai-Hong Jiang, Ya-Juan Zhang, Hui Li, Ying Jiang, Juan Zhao, Wen-Jing Guo, Jia-Yuan Guo, Lu Wang, Jia-Xuan Li, Jing Shen, Gao-Wa Jin, Ze-Wei Zhang & Quan-Fu Li. (2022) Progress in Research on Antitumor Drugs and Dynamic Changes in Skeletal Muscles. Frontiers in Pharmacology 13.
Crossref
Naomi Nakayama, Kentaro Nakayama, Tomoka Ishibashi, Satoru Katayama & Satoru Kyo. (2022) Effect of Muscle Loss but Not Fat Loss during Primary Debulking Surgery and Chemotherapy on Prognosis of Patients with Ovarian Cancer. Journal of Clinical Medicine 11:11, pages 3184.
Crossref
Paraskevi Detopoulou, Gavriela Voulgaridou & Sousana Papadopoulou. (2022) Cancer, Phase Angle and Sarcopenia: The Role of Diet in Connection with Lung Cancer Prognosis. Lung 200:3, pages 347-379.
Crossref
Luke D. Metelo-Liquito, Cleo Solomon & Deepa Bhana-Nathoo. (2022) The prevalence of sarcopenia amongst non-small cell lung cancer patients, assessed using computed tomography, prior to treatment in a South African setting. SA Journal of Oncology 6.
Crossref
Masatsugu Amitani, Takaaki Oba, Nami Kiyosawa, Hiroki Morikawa, Tatsunori Chino, Ai Soma, Tadafumi Shimizu, Koichi Ohno, Mayu Ono, Tokiko Ito, Toshiharu Kanai, Kazuma Maeno & Ken-ichi Ito. (2022) Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer. BMC Cancer 22:1.
Crossref
Stefania Rizzo, Francesco Petrella, Claudia Bardoni, Lorenzo Bramati, Andrea Cara, Shehab Mohamed, Davide Radice, Giorgio Raia, Filippo Del Grande & Lorenzo Spaggiari. (2022) CT-Derived Body Composition Values and Complications After Pneumonectomy in Lung Cancer Patients: Time for a Sex-Related Analysis?. Frontiers in Oncology 12.
Crossref
Utku Oflazoglu, Sevinc Caglar, Huriye Erbak Yılmaz, Hülya Tas Önal, Umut Varol, Tarik Salman, Yasar Yildiz, Sinan Unal, Zeynep Gulsum Guc, Yuksel Kucukzeybek, Ahmet Alacacioglu & Mustafa Oktay Tarhan. (2022) The relationship between sarcopenia detected in newly diagnosed colorectal cancer patients and FGF21, irisin and CRP levels. European Geriatric Medicine 13:4, pages 795-803.
Crossref
Bee-Song Chang, Tai-Chu Peng, Yi-Feng Wu, Tsung-Cheng Hsieh & Chun-Hou Huang. (2022) Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors. Journal of Personalized Medicine 12:3, pages 404.
Crossref
Anushree C. Shirali & Ben Sprangers. (2022) Cancer Drug Dosing in Chronic Kidney Disease and Dialysis. Advances in Chronic Kidney Disease 29:2, pages 208-216.e1.
Crossref
Han-Gyo Choi, Hye-Ah Yeom, Myung Ah Lee & Jeong-Ran Ra. (2021) A structural equation modeling approach to understanding physical function of terminal cancer patients. Supportive Care in Cancer 30:2, pages 1149-1158.
Crossref
Maria Del Grande, Stefania Rizzo, Gabriele Maria Nicolino, Ilaria Colombo, Lorenzo Rossi, Lucia Manganaro & Filippo Del Grande. (2021) Computed Tomography–Based Body Composition in Patients With Ovarian Cancer: Association With Chemotoxicity and Prognosis. Frontiers in Oncology 11.
Crossref
Claire Gallois, Camille Bourillon, Edouard Auclin, Pascal Artru, Astrid Lièvre, Thierry Lecomte, Christophe Locher, Lysiane Marthey, Roger Faroux, Simon Pernot, Maximilien Barret & Julien Taieb. (2021) Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study. Clinics and Research in Hepatology and Gastroenterology 45:6, pages 101603.
Crossref
Han-Yu Deng, Zi-Jia Chen, Xiao-Ming Qiu, Da-Xing Zhu, Xiao-Jun Tang & Qinghua Zhou. (2021) Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis. Nutrition 90, pages 111345.
Crossref
Tomohiko Shirakawa, Aki Miyawaki, Tatsuo Kawamoto & Shoichiro Kokabu. (2021) Natural Compounds Attenuate Denervation-Induced Skeletal Muscle Atrophy. International Journal of Molecular Sciences 22:15, pages 8310.
Crossref
Maria Cristina Mele, Emanuele Rinninella, Marco Cintoni, Gabriele Pulcini, Agnese Di Donato, Futura Grassi, Ilaria Trestini, Carmelo Pozzo, Giampaolo Tortora, Antonio Gasbarrini & Emilio Bria. (2021) Nutritional Support in Lung Cancer Patients: The State of the Art. Clinical Lung Cancer 22:4, pages e584-e594.
Crossref
Akihiro Miura, Hiromasa Yamamoto, Hiroki Sato, Yasuaki Tomioka, Toshio Shiotani, Ken Suzawa, Kentaroh Miyoshi, Shinji Otani, Mikio Okazaki, Seiichiro Sugimoto, Masaomi Yamane & Shinichi Toyooka. (2021) The prognostic impact of sarcopenia on elderly patients undergoing pulmonary resection for non-small cell lung cancer. Surgery Today 51:7, pages 1203-1211.
Crossref
Jongsoo Lee, Eun Young Kim, Eunji Kim, Kwang Gi Kim, Young Jae Kim, Young Saing Kim, Hee Kyung Ahn & Sang‐Woong Lee. (2021) Longitudinal changes in skeletal muscle mass in patients with advanced squamous cell lung cancer. Thoracic Cancer 12:11, pages 1662-1667.
Crossref
Cinzia Baldessari, Giorgia Guaitoli, Filippo Valoriani, Riccardo Bonacini, Raffaella Marcheselli, Linda Reverberi, Annarita Pecchi, Renata Menozzi, Pietro Torricelli, Federica Bertolini, Fausto Barbieri & Massimo Dominici. (2021) Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy. Clinical Nutrition ESPEN 43, pages 64-75.
Crossref
R. Mallet, P. Decazes, R. Modzelewski, J. Lequesne, P. Vera, B. Dubray & S. Thureau. (2021) Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC. Scientific Reports 11:1.
Crossref
Elliott J. Yee, Thomas K. Maatman, A.J. Sood, Luke Gunderman & Nicholas J. Zyromski. (2021) Dynamic frailty: Objective physiological assessment to guide management in necrotizing pancreatitis. Surgery 169:5, pages 1078-1085.
Crossref
Nicolas Williet, Marion Fovet, Khawla Maoui, Clément Chevalier, Meriem Maoui, Bertrand Le RoyXavier Roblin, Bachir Hag & Jean-Marc Phelip. (2021) A Low Total Psoas Muscle Area Index Is a Strong Prognostic Factor in Metastatic Pancreatic Cancer. Pancreas 50:4, pages 579-586.
Crossref
Jessica M. Scott, Meghan Downs, David S. Martin, Erik Hougland, Laura Sarmiento, Natalia Arzeno, Donald R. Pettit, Robert Ploutz-Snyder, David Cunningham, Lee W. Jones, Richard Do & Lori Ploutz-Snyder. (2021) Teleguided self-ultrasound scanning for longitudinal monitoring of muscle mass during spaceflight. iScience 24:4, pages 102344.
Crossref
Ching-Lung Cheung, Grace Koon-Yee Lee, Philip Chun-Ming Au, Gloria Hoi-Yee Li, Marcus Chan, Hang-Long Li, Bernard Man-Yung Cheung, Ian Chi-Kei Wong, Victor Ho-Fun Lee, James Mok, Benjamin Hon-Kei Yip, Kenneth King-Yip Cheng & Chih-Hsing Wu. (2021) Systematic review and meta-analysis of lean mass and mortality: Rationale and study description. Osteoporosis and Sarcopenia 7, pages S3-S12.
Crossref
Juha J. Hulmi, Tuuli A. Nissinen, Fabio Penna & Andrea Bonetto. (2021) Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments. Cells 10:3, pages 516.
Crossref
Aoife M. Ryan & Erin S Sullivan. (2020) Impact of musculoskeletal degradation on cancer outcomes and strategies for management in clinical practice. Proceedings of the Nutrition Society 80:1, pages 73-91.
Crossref
Fabio Efficace, Gary S. Collins, Francesco Cottone, Johannes M. Giesinger, Kathrin Sommer, Amelie Anota, Michael Maia Schlussel, Paola Fazi & Marco Vignetti. (2021) Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis. Value in Health 24:2, pages 250-267.
Crossref
Ben Sprangers, Geeta Sandhu, Mitchel H. Rosner, Petra Tesarova, Walter M. Stadler & Jolanta Malyszko. (2021) Drug dosing in cancer patients with decreased kidney function: A practical approach. Cancer Treatment Reviews 93, pages 102139.
Crossref
文星 周. (2021) Research Progress on the Effect of Body Composition Changes on Neoadjuvant Chemotherapy for Gastric Cancer. Advances in Clinical Medicine 11:11, pages 5299-5303.
Crossref
Kaipeng Duan, Xin Gao & Dongming Zhu. (2021) The clinical relevance and mechanism of skeletal muscle wasting. Clinical Nutrition 40:1, pages 27-37.
Crossref
Christine Damgaard Valan, Tarje Onsøien Halvorsen, Marit Slaaen & Bjørn Henning Grønberg. (2020) Changes in muscle measures during chemoradiotherapy in patients with limited stage small cell lung cancer. JCSM Clinical Reports 6:1, pages 24-32.
Crossref
Iain Phillips & Samantha Kestenbaum. (2020) Optimising patient fitness: strategies to reduce the effects of cancer cachexia in patients with advanced lung cancer. Current Opinion in Supportive & Palliative Care 14:4, pages 304-308.
Crossref
Song Ee Park, Jin Hwa Choi, Jae Yong Park, Beom Jin Kim, Jae Gyu Kim, Jong Won Kim, Joong-Min Park, Kyong-Choun Chi & In Gyu Hwang. (2020) Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer. Scientific Reports 10:1.
Crossref
Jongchan Lee, Jong-chan Lee, Hyoung Woo Kim, Jaihwan Kim & Jin-Hyeok Hwang. (2020) Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer. PLOS ONE 15:9, pages e0238649.
Crossref
Merran Findlay, Kathryn White, Michelle Lai, Dan Luo & Judith D. Bauer. (2020) The Association Between Computed Tomography–Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review. Journal of the Academy of Nutrition and Dietetics 120:8, pages 1330-1347.e8.
Crossref
Ben Sprangers, Ala Abudayyeh, Sheron Latcha, Mark A. Perazella & Kenar D. Jhaveri. (2020) How to determine kidney function in cancer patients?. European Journal of Cancer 132, pages 141-149.
Crossref
Timia Van Soom, Samera El Bakkali, Nick Gebruers, Hanne Verbelen, Wiebren Tjalma & Eric van Breda. (2020) The effects of chemotherapy on energy metabolic aspects in cancer patients: A systematic review. Clinical Nutrition 39:6, pages 1863-1877.
Crossref
Grant R. Williams, Yanjun Chen, Kelly M. Kenzik, Andrew McDonald, Shlomit S. Shachar, Heidi D. Klepin, Stephen Kritchevsky & Smita Bhatia. (2020) Assessment of Sarcopenia Measures, Survival, and Disability in Older Adults Before and After Diagnosis With Cancer. JAMA Network Open 3:5, pages e204783.
Crossref
Paola De Nardi, Mariachiara Salandini, Damiano Chiari, Nicolò Pecorelli, Giulia Cristel, Anna Damascelli, Monica Ronzoni, Luca Massimino, Francesco De Cobelli & Marco Braga. (2020) Changes in body composition during neoadjuvant therapy can affect prognosis in rectal cancer patients: An exploratory study. Current Problems in Cancer 44:2, pages 100510.
Crossref
Eric Chung, Hye Sun Lee, Eun-Suk Cho, Eun Jung Park, Seung Hyuk Baik, Kang Young Lee & Jeonghyun Kang. (2020) Prognostic significance of sarcopenia and skeletal muscle mass change during preoperative chemoradiotherapy in locally advanced rectal cancer. Clinical Nutrition 39:3, pages 820-828.
Crossref
Shinkichi Takamori, Tetsuzo Tagawa, Gouji Toyokawa, Mototsugu Shimokawa, Fumihiko Kinoshita, Yuka Kozuma, Taichi Matsubara, Naoki Haratake, Takaki Akamine, Fumihiko Hirai, Hiroshi Honda & Yoshihiko Maehara. (2020) Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery 109:3, pages 914-920.
Crossref
Utku Oflazoglu, Ahmet Alacacioglu, Umut Varol, Yuksel Kucukzeybek, Tarik Salman, Halil Taskaynatan, Yasar Yildiz, Ozlem Ozdemir & MustafaOktay Tarhan. (2019) Prevalence and related factors of sarcopenia in newly diagnosed cancer patients. Supportive Care in Cancer 28:2, pages 837-843.
Crossref
Brian A Hain, Baptiste Jude, Haifang Xu, Dallas M Smuin, Edward J Fox, John C Elfar & David L Waning. (2019) Zoledronic Acid Improves Muscle Function in Healthy Mice Treated with Chemotherapy. Journal of Bone and Mineral Research 35:2, pages 368-381.
Crossref
Ben Sprangers, Kenar D. Jhaveri & Mark A. Perazella. (2020) Improving Cancer Care for Patients With Chronic Kidney Disease. Journal of Clinical Oncology 38:3, pages 188-192.
Crossref
Hiroaki Nozawa, Shigenobu Emoto, Koji Murono, Yasutaka Shuno, Kazushige Kawai, Kazuhito Sasaki, Hirofumi Sonoda, Hiroaki Ishii, Yuuki Iida, Yuichiro Yokoyama, Hiroyuki Anzai & Soichiro Ishihara. (2020) Change in skeletal muscle index and its prognostic significance in patients who underwent successful conversion therapy for initially unresectable colorectal cancer: observational study. Therapeutic Advances in Gastroenterology 13, pages 175628482097119.
Crossref
Federico Bozzetti. (2020) Chemotherapy-Induced Sarcopenia. Current Treatment Options in Oncology 21:1.
Crossref
Eriko Miyawaki, Tateaki Naito, Kazuhisa Nakashima, Taichi Miyawaki, Nobuaki Mamesaya, Takahisa Kawamura, Haruki Kobayashi, Shota Omori, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Haruyasu Murakami, Keita Mori & Toshiaki Takahashi. (2020) Management of anorexia prevents skeletal muscle wasting during cisplatin‐based chemotherapy for thoracic malignancies. JCSM Clinical Reports 5:1, pages 8-15.
Crossref
Aoife M. Ryan, Carla M. Prado, Erin S. Sullivan, Derek G. Power & Louise E. Daly. (2019) Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition 67-68, pages 110539.
Crossref
E.E.C. de Jong, K.J.C. Sanders, T.M. Deist, W. van Elmpt, A. Jochems, J.E. van Timmeren, R.T.H. Leijenaar, J.H.R.J. Degens, A.M.W.J. Schols, A.-M.C. Dingemans & P. Lambin. (2019) Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer?. European Journal of Cancer 120, pages 107-113.
Crossref
Ilaria Trestini, Anastasios Gkountakos, Luisa Carbognin, Alice Avancini, Massimo Lanza, Alessio Molfino, Simonetta Friso, Vincenzo Corbo, Giampaolo Tortora, Aldo Scarpa, Michele Milella, Emilio Bria & Sara Pilotto. (2019) Muscle derangement and alteration of the nutritional machinery in NSCLC. Critical Reviews in Oncology/Hematology 141, pages 43-53.
Crossref
Sarah Santiloni Cury, Diogo de Moraes, Paula Paccielli Freire, Grasieli de Oliveira, Douglas Venâncio Pereira Marques, Geysson Javier Fernandez, Maeli Dal-Pai-Silva, Érica Nishida Hasimoto, Patricia Pintor dos Reis, Silvia Regina Rogatto & Robson Francisco Carvalho. (2019) Tumor Transcriptome Reveals High Expression of IL-8 in Non-Small Cell Lung Cancer Patients with Low Pectoralis Muscle Area and Reduced Survival. Cancers 11:9, pages 1251.
Crossref
Paula Ravasco. (2019) Nutrition in Cancer Patients. Journal of Clinical Medicine 8:8, pages 1211.
Crossref
J.H.R.J. Degens, K.J.C. Sanders, E.E.C. de Jong, H.J.M. Groen, E.F. Smit, J.G. Aerts, A.M.W.J. Schols & A.-M.C. Dingemans. (2019) The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer. Lung Cancer 133, pages 130-135.
Crossref
Ming Yang, Yanjiao Shen, Lingling Tan & Weimin Li. (2019) Prognostic Value of Sarcopenia in Lung Cancer. Chest 156:1, pages 101-111.
Crossref
Marc Hilmi, Anne Jouinot, Robert Burns, Frédéric Pigneur, Rémi Mounier, Julien Gondin, Cindy Neuzillet & François Goldwasser. (2019) Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?. Pharmacology & Therapeutics 196, pages 135-159.
Crossref
A. Secq, J. Coquart, G. Prum, A. Dujon, B. Madru, A. Radji, D. Stepowski, M. Netchitailo, D. Maure, A. Molina, A. Boutry & D. Debeaumont. (2019) Évaluation de la toxicité musculaire de la chimiothérapie lors d’une épreuve fonctionnelle à l'exercice. Revue des Maladies Respiratoires 36:3, pages 364-368.
Crossref
Hiroshi Fukushima, Yasuhisa Fujii & Fumitaka Koga. (2019) Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma. International Journal of Molecular Sciences 20:3, pages 760.
Crossref
Szilvia Vas, Rachel Povey & David Clark-Carter. (2018) ‘I would describe myself as a deformed troll’: Using interpretative phenomenological analysis to explore body image struggles among palliative care patients. Palliative Medicine 33:2, pages 232-240.
Crossref
Masayuki Okuno, Claire Goumard, Scott Kopetz, Eduardo A. Vega, Katharina Joechle, Takashi Mizuno, Ching-Wei D. Tzeng, Yun Shin Chun, Jeffrey E. Lee, Jean-Nicolas Vauthey, Thomas A. Aloia & Claudius Conrad. (2019) Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases. Surgery 165:2, pages 329-336.
Crossref
Tateaki Naito, Shuichi Mitsunaga, Satoru Miura, Noriatsu Tatematsu, Toshimi Inano, Takako Mouri, Tetsuya Tsuji, Takashi Higashiguchi, Akio Inui, Taro Okayama, Teiko Yamaguchi, Ayumu Morikawa, Naoharu Mori, Toshiaki Takahashi, Florian Strasser, Katsuhiro Omae, Keita Mori & Koichi Takayama. (2018) Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non‐small‐cell lung cancer. Journal of Cachexia, Sarcopenia and Muscle 10:1, pages 73-83.
Crossref
Tatiana Rafaela Lemos Lima, Vívian Pinto Almeida, Arthur Sá Ferreira, Fernando Silva Guimarães & Agnaldo José Lopes. (2019) Handgrip Strength and Pulmonary Disease in the Elderly: What is the Link?. Aging and disease 10:5, pages 1109.
Crossref
Takamasa Kobayashi, Hirokazu Kawai, Oki Nakano, Satoshi Abe, Hiroteru Kamimura, Akira Sakamaki, Kenya Kamimura, Atsunori Tsuchiya, Masaaki Takamura, Satoshi Yamagiwa & Shuji Terai. (2018) Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies. BMC Cancer 18:1.
Crossref
Alessio Cortellini, Pierpaolo Palumbo, Giampiero Porzio, Lucilla Verna, Aldo V. Giordano, Carlo Masciocchi, Alessandro Parisi, Katia Cannita, Corrado Ficorella & Federico Bozzetti. (2018) Single‐institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non‐small cell lung cancer patients treated with first‐line chemotherapy. Thoracic Cancer 9:12, pages 1623-1630.
Crossref
David Currow, Matthew Maddocks, David Cella & Maurizio Muscaritoli. (2018) Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia—Review and Expert Opinion. International Journal of Molecular Sciences 19:11, pages 3471.
Crossref
Alessandro Laviano, Luca Di Lazzaro & Angela Koverech. (2018) Nutrition support and clinical outcome in advanced cancer patients. Proceedings of the Nutrition Society 77:4, pages 388-393.
Crossref
Kalen J. Rimar, Alexander P. Glaser, Shilajit Kundu, Edward M. Schaeffer, Joshua Meeks & Sarah P. Psutka. (2018) Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer. Bladder Cancer 4:4, pages 411-418.
Crossref
Jonas Sørensen. (2018) Lung Cancer Cachexia: Can Molecular Understanding Guide Clinical Management?. Integrative Cancer Therapies 17:3, pages 1000-1008.
Crossref
Elizabeth M. Cespedes FelicianoCandyce H. KroenkeBette J. Caan. (2018) The Obesity Paradox in Cancer: How Important Is Muscle?. Annual Review of Nutrition 38:1, pages 357-379.
Crossref
Alejandro Recio-Boiles, Jose N. Galeas, Bernard Goldwasser, Karla Sanchez, Louise M. W. Man, Ryan D. Gentzler, Jane Gildersleeve, Patricia J. Hollen & Richard J. Gralla. (2018) Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT). Supportive Care in Cancer 26:7, pages 2353-2359.
Crossref
Federica Mazzuca, Concetta Elisa Onesti, Michela Roberto, Marco Di Girolamo, Andrea Botticelli, Paola Begini, Lidia Strigari, Paolo Marchetti & Maurizio Muscaritoli. (2018) Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines. Oncotarget 9:39, pages 25714-25722.
Crossref
Shinkichi Takamori, Gouji Toyokawa, Tatsuro Okamoto, Mototsugu Shimokawa, Fumihiko Kinoshita, Yuka Kozuma, Taichi Matsubara, Naoki Haratake, Takaki Akamine, Kazuki Takada, Masakazu Katsura, Fumihiko Hirai, Fumihiro Shoji, Tetsuzo Tagawa, Yoshinao Oda, Hiroshi Honda & Yoshihiko Maehara. (2018) Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer. Annals of Surgical Oncology 25:5, pages 1229-1236.
Crossref
Hiroshi Shimokata, Hiroyuki Shimada, Shosuke Satake, Naoto Endo, Koji Shibasaki, Sumito Ogawa & Hidenori Arai. (2018) Chapter 2 Epidemiology of sarcopenia. Geriatrics & Gerontology International 18:S1, pages 13-22.
Crossref
L. E. Daly, C. M. Prado & A. M. Ryan. (2018) A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes. Proceedings of the Nutrition Society 77:2, pages 135-151.
Crossref
M.D. Goncalves, S. Taylor, D.F. Halpenny, E. Schwitzer, S. Gandelman, J. Jackson, A. Lukose, A.J. Plodkowski, K.S. Tan, M. Dunphy, L.W. Jones & R.J. Downey. (2018) Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer. Clinical Radiology 73:5, pages 505.e1-505.e8.
Crossref
Louise E. Daly, Éadaoin B. Ní Bhuachalla, Derek G. Power, Samantha J. Cushen, Karl James & Aoife M. Ryan. (2018) Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer. Journal of Cachexia, Sarcopenia and Muscle 9:2, pages 315-325.
Crossref
Éadaoin B. Ní Bhuachalla, Louise E. Daly, Derek G. Power, Samantha J. Cushen, Peter MacEneaney & Aoife M. Ryan. (2018) Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?. Journal of Cachexia, Sarcopenia and Muscle 9:2, pages 295-305.
Crossref
R Dev, E. Bruera & S. Dalal. (2018) Insulin resistance and body composition in cancer patients. Annals of Oncology 29, pages ii18-ii26.
Crossref
Marcus D. GoncalvesSeo-Kyoung HwangChantal PauliCharles J. MurphyZhe ChengBenjamin D. HopkinsDavid WuRyan M. LoughranBrooke M. EmerlingGuoan ZhangDouglas T. Fearon & Lewis C. Cantley. (2018) Fenofibrate prevents skeletal muscle loss in mice with lung cancer. Proceedings of the National Academy of Sciences 115:4.
Crossref
Kazutaka Kakinuma, Hazime Tsuruoka, Kei Morikawa, Naoki Furuya, Takeo Inoue, Teruomi Miyazawa & Masamichi Mineshita. (2018) Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non-small cell lung cancer. Thoracic Cancer 9:1, pages 99-104.
Crossref
Verônica Torres da Costa e Silva, Elerson C. Costalonga, Fernanda O. Coelho, Renato A. Caires & Emmanuel A. Burdmann. (2018) Assessment of Kidney Function in Patients With Cancer. Advances in Chronic Kidney Disease 25:1, pages 49-56.
Crossref
Tateaki Naito, Taro Okayama, Takashi Aoyama, Takuya Ohashi, Yoshiyuki Masuda, Madoka Kimura, Hitomi Shiozaki, Haruyasu Murakami, Hirotsugu Kenmotsu, Tetsuhiko Taira, Akira Ono, Kazushige Wakuda, Hisao Imai, Takuya Oyakawa, Takeshi Ishii, Shota Omori, Kazuhisa Nakashima, Masahiro Endo, Katsuhiro Omae, Keita Mori, Nobuyuki Yamamoto, Akira Tanuma & Toshiaki Takahashi. (2017) Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non–small-cell lung cancer. BMC Cancer 17:1.
Crossref
Makito Miyake, Yosuke Morizawa, Shunta Hori, Nagaaki Marugami, Keiji Shimada, Daisuke Gotoh, Yoshihiro Tatsumi, Yasushi Nakai, Takeshi Inoue, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Nobumichi Tanaka & Kiyohide Fujimoto. (2017) Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder. BMC Cancer 17:1.
Crossref
Philippe Caillet, Evelyne Liuu, Agathe Raynaud Simon, Marc Bonnefoy, Olivier Guerin, Gilles Berrut, Bruno Lesourd, Claude Jeandel, Monique Ferry, Yves Rolland & Elena Paillaud. (2017) Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review. Clinical Nutrition 36:6, pages 1473-1482.
Crossref
Philippe Atlan, Mohamed Amine Bayar, Emilie Lanoy, Benjamin Besse, David Planchard, Jordy Ramon, Bruno Raynard & Sami Antoun. (2017) Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study. Supportive Care in Cancer 25:11, pages 3365-3373.
Crossref
F. Bozzetti. (2017) Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Annals of Oncology 28:9, pages 2107-2118.
Crossref
Weijie Gu, Junlong Wu, Xiaohang Liu, Hailiang Zhang, Guohai Shi, Yao Zhu & Dingwei Ye. (2017) Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients. Scientific Reports 7:1.
Crossref
Jessica M. Scott, David S. Martin, Robert Ploutz-Snyder, Timothy Matz, Timothy Caine, Meghan Downs, Kyle Hackney, Roxanne Buxton, Jeffrey W. Ryder & Lori Ploutz-Snyder. (2017) Panoramic ultrasound: a novel and valid tool for monitoring change in muscle mass. Journal of Cachexia, Sarcopenia and Muscle 8:3, pages 475-481.
Crossref
Hiroshi Fukushima, Yasukazu Nakanishi, Madoka Kataoka, Ken-ichi Tobisu & Fumitaka Koga. (2017) Postoperative Changes in Skeletal Muscle Mass Predict Survival of Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy. Clinical Genitourinary Cancer 15:2, pages e229-e238.
Crossref
Hánah N. Rier, Agnes Jager, Stefan Sleijfer, Joost van Rosmalen, Marc C.J.M. Kock & Mark-David Levin. (2017) Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy. The Breast 31, pages 9-15.
Crossref
Eric J. Roeland, Joseph D. Ma, Sandahl H. Nelson, Tyler Seibert, Sean Heavey, Carolyn Revta, Andrea Gallivan & Vickie E. Baracos. (2016) Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials. Supportive Care in Cancer 25:2, pages 365-369.
Crossref
Johanna Nattenmüller, Raoul Wochner, Thomas Muley, Martin Steins, Simone Hummler, Birgit Teucher, Joachim Wiskemann, Hans-Ulrich Kauczor, Mark Oliver Wielpütz & Claus Peter Heussel. (2017) Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients. PLOS ONE 12:1, pages e0169136.
Crossref
Louise E Daly, Derek G Power, Áine O'Reilly, Paul Donnellan, Samantha J Cushen, Kathleen O'Sullivan, Maria Twomey, David P Woodlock, Henry P Redmond & Aoife M Ryan. (2017) The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma. British Journal of Cancer 116:3, pages 310-317.
Crossref
Maria Cecília Monteiro Dela Vega, Alessandro Laviano & Gustavo Duarte Pimentel. (2016) Sarcopenia and chemotherapy-mediated toxicity. Einstein (São Paulo) 14:4, pages 580-584.
Crossref
Hánah N. Rier, Agnes Jager, Stefan Sleijfer, Andrea B. Maier & Mark-David Levin. (2016) The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature. The Oncologist 21:11, pages 1396-1409.
Crossref
Susanne Blauwhoff-Buskermolen, Marian A.E. de van der Schueren, Jacqueline A.E. Langius & Henk M.W. Verheul. (2016) Reply to L.E. Daly et al. Journal of Clinical Oncology 34:31, pages 3817-3817.
Crossref
Louise E. Daly, Aoife M. Ryan & Derek G. Power. (2016) Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer”. Journal of Clinical Oncology 34:31, pages 3816-3817.
Crossref
Rafael Barreto, Giorgia Mandili, Frank A. Witzmann, Francesco Novelli, Teresa A. Zimmers & Andrea Bonetto. (2016) Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways. Frontiers in Physiology 7.
Crossref
Iris J.G. Rutten, David P.J. van Dijk, Roy F.P.M. Kruitwagen, Regina G.H. Beets-Tan, Steven W.M. Olde Damink & Toon van Gorp. (2016) Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. Journal of Cachexia, Sarcopenia and Muscle 7:4, pages 458-466.
Crossref
Rafael Barreto, David L. Waning, Hongyu Gao, Yunlong Liu, Teresa A. Zimmers & Andrea Bonetto. (2016) Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs. Oncotarget 7:28, pages 43442-43460.
Crossref
Jean-Louis Pujol. (2016) Is Weight Loss a Loss of Chance in Patients Receiving Chemoradiotherapy?. Journal of Thoracic Oncology 11:6, pages 787-788.
Crossref
C. M. Prado, S. J. Cushen, C. E. Orsso & A. M. Ryan. (2016) Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact. Proceedings of the Nutrition Society 75:2, pages 188-198.
Crossref
Susanne Blauwhoff-BuskermolenKathelijn S. VersteegMarian A.E. de van der SchuerenNicole R. den BraverJohannes BerkhofJacqueline A.E. LangiusHenk M.W. Verheul. (2016) Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology 34:12, pages 1339-1344.
Crossref
Shlomit Strulov Shachar, Grant R. Williams, Hyman B. Muss & Tomohiro F. Nishijima. (2016) Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. European Journal of Cancer 57, pages 58-67.
Crossref
Jarin Chindapasirt. (2016) Sarcopenia in Cancer Patients. Asian Pacific Journal of Cancer Prevention 16:18, pages 8075-8077.
Crossref
Alessandro Laviano, Angela Koverech & Alessia Mari. (2015) Cachexia: clinical features when inflammation drives malnutrition. Proceedings of the Nutrition Society 74:4, pages 348-354.
Crossref
H. J. Leach, J. A. Devonish, D. G. Bebb, K. A. Krenz & S. N. Culos-Reed. (2015) Exercise preferences, levels and quality of life in lung cancer survivors. Supportive Care in Cancer 23:11, pages 3239-3247.
Crossref
Yuji Miyamoto, Yoshifumi Baba, Yasuo Sakamoto, Mayuko Ohuchi, Ryuma Tokunaga, Junji Kurashige, Yukiharu Hiyoshi, Shiro Iwagami, Naoya Yoshida, Masayuki Watanabe & Hideo Baba. (2015) Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer. PLOS ONE 10:6, pages e0129742.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.